Kim Chan Koh
Corporate Officer/Principal at The Royal Australasian College of Physicians
Network origin in Kim Chan Koh first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The Royal College of Physicians
117
| College/University | Other Consumer Services | 117 |
The Royal Australasian College of Physicians
3
| Non-Profit Organization | 3 | |
| Holding Company | Financial Conglomerates | 2 | |
| Private Company | Investment Banks/Brokers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kim Chan Koh via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Hong Kong | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| National University of Singapore | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | ||
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Edinburgh | College/University | Undergraduate Degree Director/Board Member Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Leeds | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Malaya | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Glasgow | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The University of Manchester | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| OXFORD BIOMEDICA PLC | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal | |
| Trinity College Dublin | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Hong Kong College of Physicians
 Hong Kong College of Physicians Miscellaneous Commercial ServicesCommercial Services The Hong Kong College of Physicians operates an association of physicians. The private company is based in Hong Kong, Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ATHENEXPAR | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Birmingham | College/University | Undergraduate Degree Masters Business Admin | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Royal Free Hospital Medical School | College/University | Doctorate Degree Doctorate Degree | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Hong Kong Medical Association | Corporate Officer/Principal Corporate Officer/Principal | ||
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Cardiorentis AG
 Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CellVec Pte Ltd. | Chairman Director/Board Member | ||
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| American Academy of Pharmaceutical Physicians | Corporate Officer/Principal Director/Board Member | ||
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Chinese University of Hong Kong | College/University | Graduate Degree Undergraduate Degree | |
| Medical Oncology Specialist Clinic Pte Ltd. | Director/Board Member Director/Board Member |
Statistics
International
| United States | 18 |
| United Kingdom | 17 |
| Hong Kong | 5 |
| Singapore | 4 |
| Switzerland | 3 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 19 |
| Health Services | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 532 |
| Corporate Officer/Principal | 354 |
| Chief Tech/Sci/R&D Officer | 134 |
| Independent Dir/Board Member | 76 |
| Chairman | 75 |
Most connected contacts
| Insiders | |
|---|---|
| Cheok Peng Lim | 128 |
| Chrisantha Nicholas Nonis | 47 |
| Tong Choon Cheo | 44 |
| Frank Armstrong | 41 |
| Freda Lewis-Hall | 29 |
| Ik King Tiong | 29 |
| Christine Bennett | 27 |
| Yiu Nam Lau | 26 |
| Peng Tiam Ang | 26 |
| Preetinder Singh Joshi | 23 |
| Paul Blake | 23 |
| Kei Siong Khoo | 23 |
| James Shannon | 22 |
| Warren Cooper | 21 |
| David J. Clark | 21 |
- Stock Market
- Insiders
- Kim Chan Koh
- Company connections
